Fractyl Health, Inc. Common Stock (GUTS)
NASDAQ·Healthcare·Biotechnology
$0.65
+0.00%
Mkt Cap $47.15M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 24, 2026 | — | — | — | -$0.19 | $0.15 | +178.95% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.34 | -$0.35 | -2.94% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.37 | -$0.53 | -43.24% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.49 | -$0.49 | +0.00% | — | — |
| Q1 2025 Mar 3, 2025 | $10.00K | $3.00K | -70.00% | -$0.44 | -$0.52 | -18.18% | — | — |
| Q4 2024 Nov 12, 2024 | — | $14.00K | — | -$0.50 | -$0.48 | +4.00% | — | — |
| Q3 2024 Aug 14, 2024 | — | $43.00K | — | -$0.46 | -$0.36 | +21.74% | — | — |
| Q2 2024 May 13, 2024 | — | $33.00K | — | -$0.30 | -$0.75 | -150.00% | — | — |
| Q2 2024 Apr 1, 2024 | — | $7.00K | — | -$0.65 | -$8.02 | -1133.85% | — | — |
| Q3 2023 Sep 30, 2023 | — | $36.00K | — | — | -$0.33 | — | — | — |
| Q2 2023 Jun 30, 2023 | — | $72.00K | — | — | -$0.63 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | $5.00K | — | — | -$0.25 | — | — | — |
| Q4 2022 Dec 30, 2022 | — | — | — | — | -$0.23 | — | — | — |
| Q3 2022 Sep 30, 2022 | — | — | — | — | -$7.54 | — | — | — |
| Q4 2021 Dec 30, 2021 | — | — | — | — | -$0.26 | — | — | — |
| Q3 2021 Sep 29, 2021 | — | — | — | — | -$0.19 | — | — | — |
| Q4 2020 Dec 30, 2020 | — | — | — | — | -$0.17 | — | — | — |
| Q3 2020 Sep 29, 2020 | — | — | — | — | -$0.16 | — | — | — |